down arrow

Bharat Immunolog

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE994B01014
  • NSEID:
  • BSEID: 524663
INR
22.49
0.42 (1.9%)
BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 8.38 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

21.8122.65

52 Week

19.0035.88
Valuation
Technical
Day's Volume

CASH

8.38 k (-82.77%) Volume

Shareholding (Mar 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

59.25%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

  • Poor long term growth as Net Sales has grown by an annual rate of -24.67% and Operating profit at -229.01% over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
2

Negative results in Sep 23

3

Stock is technically in a Bearish range

4

Risky - No result in last 6 months

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 97 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.83

stock-summary
Return on Equity

-22.96%

stock-summary
Price to Book

1.21

Revenue and Profits (1 Year):
Net Sales:
(Quarterly Results - Sep 2023)
Net Profit:
-5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-16.73%
0%
-16.73%
1 Year
-28.44%
0%
-28.44%
2 Years
-20.61%
0%
-20.61%
3 Years
-38.97%
0%
-38.97%
4 Years
-44.4%
0%
-44.4%
5 Years
200.67%
0%
200.67%

Bharat Immunolog for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-24.67%
EBIT Growth (5y)
-170.32%
EBIT to Interest (avg)
-4.32
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.80
Sales to Capital Employed (avg)
0.83
Tax Ratio
20.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-25.80%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
1.21
EV to EBIT
-8.96
EV to EBITDA
-9.06
EV to Capital Employed
1.12
EV to Sales
21.01
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-12.44%
ROE (Latest)
-22.96%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

President Of India (59.25%)

Highest Public shareholder

None

Individual Investors Holdings

39.47%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'23 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2023 is 0.00% vs -100.00% in Jun 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2023 is -7.19% vs -18.30% in Jun 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'23",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.69",
          "val2": "-4.32",
          "chgp": "-8.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.09",
          "val2": "1.72",
          "chgp": "21.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-4.92",
          "val2": "-4.59",
          "chgp": "-7.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2023 is -100.00% vs -16.96% in Sep 2022",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2023 is -17.70% vs -73.76% in Sep 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'23",
        "Sep'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "36.96",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-9.00",
          "val2": "-7.33",
          "chgp": "-22.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.81",
          "val2": "3.32",
          "chgp": "14.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-9.51",
          "val2": "-8.08",
          "chgp": "-17.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-19.83%",
          "chgp": "19.83%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2022 is -46.98% vs 59.96% in Dec 2020",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2022 is -95.11% vs 53.22% in Dec 2020",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'20",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "36.96",
          "val2": "69.71",
          "chgp": "-46.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-12.05",
          "val2": "-6.14",
          "chgp": "-96.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.99",
          "val2": "3.56",
          "chgp": "40.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-12.76",
          "val2": "-6.54",
          "chgp": "-95.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-32.60%",
          "val2": "-8.81%",
          "chgp": "-23.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2023 is -43.09% vs -8.13% in Mar 2022",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2023 is -94.97% vs 33.10% in Mar 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'23",
        "Mar'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "44.61",
          "val2": "78.39",
          "chgp": "-43.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-18.46",
          "val2": "-4.99",
          "chgp": "-269.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.04",
          "val2": "5.59",
          "chgp": "25.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-17.06",
          "val2": "-8.75",
          "chgp": "-94.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-41.38%",
          "val2": "-6.37%",
          "chgp": "-35.01%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'23 - QoQstock-summary
Sep'23
Jun'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-4.69
-4.32
-8.56%
Interest
2.09
1.72
21.51%
Exceptional Items
0.00
0.00
Standalone Net Profit
-4.92
-4.59
-7.19%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2023 is 0.00% vs -100.00% in Jun 2023

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2023 is -7.19% vs -18.30% in Jun 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'23stock-summary
Sep'23
Sep'22
Change(%)
Net Sales
0.00
36.96
-100.00%
Operating Profit (PBDIT) excl Other Income
-9.00
-7.33
-22.78%
Interest
3.81
3.32
14.76%
Exceptional Items
0.00
0.00
Standalone Net Profit
-9.51
-8.08
-17.70%
Operating Profit Margin (Excl OI)
0.00%
-19.83%
19.83%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2023 is -100.00% vs -16.96% in Sep 2022

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2023 is -17.70% vs -73.76% in Sep 2022

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'22stock-summary
Dec'22
Dec'20
Change(%)
Net Sales
36.96
69.71
-46.98%
Operating Profit (PBDIT) excl Other Income
-12.05
-6.14
-96.25%
Interest
4.99
3.56
40.17%
Exceptional Items
0.00
0.00
Standalone Net Profit
-12.76
-6.54
-95.11%
Operating Profit Margin (Excl OI)
-32.60%
-8.81%
-23.79%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2022 is -46.98% vs 59.96% in Dec 2020

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2022 is -95.11% vs 53.22% in Dec 2020

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'23stock-summary
Mar'23
Mar'22
Change(%)
Net Sales
44.61
78.39
-43.09%
Operating Profit (PBDIT) excl Other Income
-18.46
-4.99
-269.94%
Interest
7.04
5.59
25.94%
Exceptional Items
0.00
0.00
Standalone Net Profit
-17.06
-8.75
-94.97%
Operating Profit Margin (Excl OI)
-41.38%
-6.37%
-35.01%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2023 is -43.09% vs -8.13% in Mar 2022

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2023 is -94.97% vs 33.10% in Mar 2022

All Annual Resultsstock-summary
stock-summaryCompany CV
About Bharat Immunological & Biological Corporation Ltd stock-summary
stock-summary
Bharat Immunological & Biological Corporation Ltd
Micro Cap
Pharmaceuticals & Drugs
The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology. BIBCOL was incorporated in 1989. The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh. BIBCL installed a plant of 100 mln units.
Company Coordinates stock-summary
Company Details
BIBCOL OPV Plant Village Chola , Bulandshahr Uttar Pradesh : 203203
stock-summary
Tel: 91-5732-238210
stock-summary
http://www.bibcol.com
stock-summary
Registrar Details
MAS Services Ltd, T-34 , 2nd Floor, Okhla Industrial Area, Phase - II, New Delhi
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."